Amino Acid Supplementation in Recovery From Severe Burns (ExAA)

The University of Texas System (UT)

Status: Completed

Conditions: Burn Injury

Treatments: Dietary Supplement: Placebo + Exercise Training; Dietary Supplement: EAA Supplementation + Exercise Training

Study type: Interventional

Funder types: Other

Identifiers

NCT01618630

12-048

Details and patient eligibility

About

Exercise during recovery is now Standard of Care at Shriners Hospital for Children Galveston, since positive effects of exercise training were found on lean body mass and recovery after burns. Essential amino acids (EAA) effective in healthy individuals.Thus, EAA supplementation in children recovering from burns, may potentially augment the effects of exercise by increase muscle mass, improve muscle fat oxidation, reduce tissue fat, and possibly improve insulin resistance.

Full description

Severe burns result in persistent and extensive fat deposition in liver and muscle tissue. This may be related to the prolonged insulin resistance observed following burn. In this study the investigators will test the hypothesis that essential amino acids act in synergy with exercise to improve liver steatosis and muscle lipid metabolism, and thus also affect insulin sensitivity. Children with burns will participate in six weeks of exercise training with/without amino acid supplementation. Before and after the intervention, measurements will be done to determine muscle and liver fat content, muscle fat and protein metabolism, and insulin sensitivity.

We will prospectively enroll 40 children with ≥30% of their total body surface area (TBSA) burned. The age range will be 7-17 years. Children will be recruited from Shriners Hospitals for Children (SHC)-Galveston. Burned children will be randomized to undergo an exercise program in combination with daily intake of EAA (n=20) or a placebo drink (n=20). The exercise program and daily intake of AA will begin within the first week of discharge from the burn ICU (approximately 1-3 months post burn, when the patient's wounds are 95% healed). The definition of 95% healed is 7 days after the final autografting procedure. We anticipate enrolling 10 children per year for 4 years. Only children meeting the inclusion and exclusion criteria specified in the Human Subjects Section will be enrolled.

Nutritional Supplement: The nutritional supplement will be administered at a dose of 0.18 g/kg body weight of amino acids two times per day with the following composition: 3% histidine, 9% isoleucine, 36% leucine, 17% lysine, 4% methionine, 5% phenylalanine, 10% threonine, 7% valine, and 10% arginine. The dose and choice of amino acids is based on our preliminary data. Each dose is about 0.03 g/kg body weight higher than what has been shown effective in adults, as children have higher protein needs. We have shown that only EAA are needed to affect muscle protein synthesis and lean mass. Thus the amount given (g or kcal) can be restricted. As in our preliminary studies, we will include arginine in the EAA mixture, since arginine may have unique anabolic effects (55; 86). Placebo will consist of a mixture of inert components (sucralose and other pharmaceutical excipients). The supplement will be taken in two daily doses in the form of drinks (total daily dose of i.e., 0.30 g/kg body weight total per day), and intake recorded in a diary. The first dose will be taken between breakfast and lunch, and the second between lunch and dinner. For the children exercising before lunch, the first dose of EAA will be ingested immediately after exercise. Correspondingly, for children exercising after lunch, the second EAA dose of the day will be ingested immediately after exercise. If the child forgets to take one of the drinks during the day, he/she may take the second one between dinner and bedtime. During the weekends, parents/caregivers are instructed to take the dosage around the same time.

Data Analysis and Interpretation. To determine effects of amino acids on fat and muscle lipid stores, changes from pre- to post intervention in the two groups will be compared using ANCOVA. From the preliminary data, we expect that amino acids will decrease liver and plasma lipids.

Enrollment: 20 patients

Sex: All

Ages: 7 to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Male or female
2. 7-17 years old
3. Body weight >20 kg (based on blood requirements)
4. ≥30% Total Body Surface Area (TBSA)
5. Wounds 95% healed

Exclusion criteria

1. Respiratory insufficiency
2. Multiple fractures
3. History of Cancer in the last 5 years
4. Diabetes Mellitus
5. Bilirubin > 3 mg/dl
6. Associated head injuries requiring specific therapy
7. Associated injuries to chest or abdomen requiring surgery
8. Serum creatinine > 3 mg/dl after fluid resuscitation
9. Receipt of any experimental drug other than the ones supplied within two months of this study
10. Any metal in body including rods, cardiac defibrillator, pacemakers, etc
11. Orthopedic casting which would prevent placement of patient in MRI machine
12. Hepatitis
13. Abnormal EKG
14. Electrical burns
15. Patients unable to lie still without heavy sedation will be excluded from MRI portion.

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

20 participants in 2 patient groups, including a placebo group

EAA Supplementation + Exercise Training

Experimental group

Description:

Drink an amino acid supplementation during exercise training.

Treatment:

Dietary Supplement: EAA Supplementation + Exercise Training

Placebo + Exercise Training

Placebo Comparator group

Description:

Drink a placebo supplementation during exercise training.

Treatment:

Dietary Supplement: Placebo + Exercise Training